Angelalign Technology's Subsidiary to Purchase Raw Materials for Aligner Production

MT Newswires Live

02-20

Angelalign Technology's (HKG:6699) subsidiary Wuxi EA Medical Instruments Technologies agreed to purchase certain raw materials from Shanghai Maxflex Medical Technology, a Wednesday bourse filing said.

The materials will be used for the production of clear aligners.

The annual caps set for the transaction are 30 million yuan for 2025, 42 million yuan for 2026, and 58.8 million yuan for 2027.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2512411928"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2512411928\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2512411928?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-20 17:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2512411928","market":"us","top_or_hot":-1,"title":"Angelalign Technology's Subsidiary to Purchase Raw Materials for Aligner Production","media":"MT Newswires Live","content":"<html><body><p> Angelalign Technology's (HKG:6699) subsidiary Wuxi EA Medical Instruments Technologies agreed to purchase certain raw materials from Shanghai Maxflex Medical Technology, a Wednesday bourse filing said.</p><p>The materials will be used for the production of clear aligners.</p><p>The annual caps set for the transaction are 30 million yuan for 2025, 42 million yuan for 2026, and 58.8 million yuan for 2027.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Angelalign Technology's Subsidiary to Purchase Raw Materials for Aligner Production</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAngelalign Technology's Subsidiary to Purchase Raw Materials for Aligner Production\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-02-20 17:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Angelalign Technology's (HKG:6699) subsidiary Wuxi EA Medical Instruments Technologies agreed to purchase certain raw materials from Shanghai Maxflex Medical Technology, a Wednesday bourse filing said.</p><p>The materials will be used for the production of clear aligners.</p><p>The annual caps set for the transaction are 30 million yuan for 2025, 42 million yuan for 2026, and 58.8 million yuan for 2027.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06699","symbol_name":"时代天使","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2512411928","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2512411928","pubTimestamp":1740044573,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Angelalign Technology's  subsidiary Wuxi EA Medical Instruments Technologies agreed to purchase certain raw materials from Shanghai Maxflex Medical Technology, a Wednesday bourse filing said.The materials will be used for the production of clear aligners.The annual caps set for the transaction are 30 million yuan for 2025, 42 million yuan for 2026, and 58.8 million yuan for 2027.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06699":"时代天使","BK4544":"ARK ETF合集","BK1100":"医疗保健设备","BK1593":"医美概念股","BK4585":"ETF&股票定投概念","ARKG":"ARK Genomic Revolution ETF","BK4588":"碎股","BK1587":"次新股","BK1583":"高瓴概念"},"translate_title":"时代天使科技子公司将采购原材料用于矫直机生产","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06699":1,"ARKG":1},"content_text":"Angelalign Technology's (HKG:6699) subsidiary Wuxi EA Medical Instruments Technologies agreed to purchase certain raw materials from Shanghai Maxflex Medical Technology, a Wednesday bourse filing said.The materials will be used for the production of clear aligners.The annual caps set for the transaction are 30 million yuan for 2025, 42 million yuan for 2026, and 58.8 million yuan for 2027.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0}}}